These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34503114)
1. The Prognostic Effect of Wahl SGF; Dai HY; Emdal EF; Berg T; Halvorsen TO; Ottestad AL; Lund-Iversen M; Brustugun OT; Førde D; Paulsen EE; Donnem T; Andersen S; Grønberg BH; Richardsen E Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503114 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Wu SG; Liao WY; Su KY; Yu SL; Huang YL; Yu CJ; Chih-Hsin Yang J; Shih JY JTO Clin Res Rep; 2021 Feb; 2(2):100140. PubMed ID: 34589991 [TBL] [Abstract][Full Text] [Related]
3. Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer. Cui W; Franchini F; Alexander M; Officer A; Wong HL; IJzerman M; Desai J; Solomon BJ Lung Cancer; 2020 Aug; 146():310-317. PubMed ID: 32619782 [TBL] [Abstract][Full Text] [Related]
4. KRAS mutated Non-Small Lung Carcinoma: A Real World Context from the Indian subcontinent. Batra U; Nathany S; Sharma M; Bp A; Jose JT; Singh H; Mattoo S; Mehta A Cancer Med; 2023 Feb; 12(3):2869-2874. PubMed ID: 36069080 [TBL] [Abstract][Full Text] [Related]
5. [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Guo LY; Xiang C; Zhao RY; Chen SN; Ma SJ; Han YC Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):117-123. PubMed ID: 36748130 [No Abstract] [Full Text] [Related]
6. A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations. Lei L; Wang WX; Yu ZY; Liang XB; Pan WW; Chen HF; Wang LP; Fang Y; Wang M; Xu CW; Fang MY Transl Oncol; 2020 Feb; 13(2):329-335. PubMed ID: 31881505 [TBL] [Abstract][Full Text] [Related]
7. Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. Julian C; Pal N; Gershon A; Evangelista M; Purkey H; Lambert P; Shi Z; Zhang Q BMC Cancer; 2023 Apr; 23(1):352. PubMed ID: 37069542 [TBL] [Abstract][Full Text] [Related]
8. Outcomes and prognostic contributors in patients with Burns EA; Ensor JE; Hsu J; Thomas JS; Olsen RJ; Bernicker EH J Thorac Dis; 2021 Aug; 13(8):4785-4796. PubMed ID: 34527319 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Implication of Noordhof AL; Swart EM; Damhuis RAM; Hendriks LEL; Kunst PWA; Aarts MJ; van Geffen WH JTO Clin Res Rep; 2023 Sep; 4(9):100543. PubMed ID: 37674812 [TBL] [Abstract][Full Text] [Related]
13. KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry. Isaksson J; Berglund A; Louie K; Willén L; Hamidian A; Edsjö A; Enlund F; Planck M; Vikström A; Johansson M; Hallqvist A; Wagenius G; Botling J Clin Lung Cancer; 2023 Sep; 24(6):507-518. PubMed ID: 37296038 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic value of the Liu SY; Sun H; Zhou JY; Jie GL; Xie Z; Shao Y; Zhang X; Ye JY; Chen CX; Zhang XC; Zhou Q; Yang JJ; Wu YL Biomark Res; 2020; 8():22. PubMed ID: 32607238 [TBL] [Abstract][Full Text] [Related]
15. Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy. Justeau G; Huchot E; Simonneau Y; Roa M; Le Treut J; Le Garff G; Bylicki O; Schott R; Bravard AS; Tiercin M; Lamy R; De Chabot G; Marty A; Moreau D; Locher C; Bernier C; Chouaid C; Descourt R Lung Cancer; 2022 Dec; 174():45-49. PubMed ID: 36323057 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of Jing Y; Cheng R; Zeng H; Huang Q; He D; Sun J; Tian P; Li Y Int J Gen Med; 2024; 17():4507-4517. PubMed ID: 39386149 [TBL] [Abstract][Full Text] [Related]
17. A retrospective observational study of the natural history of advanced non-small-cell lung cancer in patients with KRAS p.G12C mutated or wild-type disease. Spira AI; Tu H; Aggarwal S; Hsu H; Carrigan G; Wang X; Ngarmchamnanrith G; Chia V; Gray JE Lung Cancer; 2021 Sep; 159():1-9. PubMed ID: 34293517 [TBL] [Abstract][Full Text] [Related]
18. The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study. Chida K; Kotani D; Masuishi T; Kawakami T; Kawamoto Y; Kato K; Fushiki K; Sawada K; Kumanishi R; Shirasu H; Matsubara Y; Yuki S; Komatsu Y; Yamazaki K; Yoshino T Oncologist; 2021 Oct; 26(10):845-853. PubMed ID: 34232546 [TBL] [Abstract][Full Text] [Related]